B-cell depletion for 2 years after autologous stem cell transplant for NHL induces prolonged hypogammaglobulinemia beyond the rituximab maintenance period

Leukemia and Lymphoma

Volumn 49, Issue 1, 2008, Pages 152-153

  Lim, Seah ^a   Esler, William ^a   Zhang, Yana ^a   Zhang, Jian ^a   Periman, Phillip ^a   Burris, Colleen ^a   Townsend, Mary ^a  

^a TEXAS ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MELPHALAN; PREDNISOLONE; RITUXIMAB; THIOTEPA; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG INFUSION; DRUG MEGADOSE; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; LARGE CELL LYMPHOMA; LOW DRUG DOSE; LYMPHOCYTE DEPLETION; MAINTENANCE THERAPY; MALE; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL TIME;

ADULT; AGAMMAGLOBULINEMIA; AGED; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN ISOTYPES; LYMPHOCYTE DEPLETION; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 38549158415     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701742506     Document Type: Article

References (5)

1. Lim, S. H., Zhang, Y., Wang, Z., Esler, W. V., Beggs, D., Pruitt, B., Hancock, P. and Townsend, M. (2005) Maintenance rituximab after autologous stem cell transplant for high-risk B-cell lymphoma induces prolonged and severe hypogammaglobulinemia. Bone Marrow Transpl, 35, pp. 207-208.
2. Lim, S. H., Zhang, Y., Wang, Z., Varadarajan, R., Periman, P. and Esler, W. V. (2004) Rituximab administration following autologous stem cell transplant for multiple myeloma is associated with severe IgM deficiency. Blood, 103, pp. 1971-1972.
3. Ashihara, E., Shimazaki, C., Yamagata, N., Hirata, T., Okawa, K. and Oku, N. (1994) Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: Two-color flow cytometric analysis. Bone Marrow Transpl, 13, pp. 377-381.
4. Koehne, G., Zeller, W., Stockschlaeder, M. and Zander, A. R. (1997) Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation. Bone Marrow Transpl, 19, pp. 149-156.
5. Talmadge, J. E., Reed, E., Ino, K., Kessinger, A., Kuszynski, C. and Heimann, D. (1997) Rapid immunologic reconstitution following blood stem cells as compared to bone marrow. Bone Marrow Transpl, 19, pp. 161-172.